Project 3: Elemental Microscopy for Detection of Radionuclide Distribution and Development of Cell and Tissue Phantoms
项目 3:用于检测放射性核素分布和细胞和组织模型开发的元素显微镜
基本信息
- 批准号:10327398
- 负责人:
- 金额:$ 37.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-10 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcuteAddressAffectAnimal ModelAnimalsArchivesBackBiologicalBiological MarkersCanis familiarisCell DeathCell LineageCellsChemicalsChemistryComplexDNA DamageDataDaughterDepositionDetectionDevelopmentDevicesDimensionsDiscipline of Nuclear MedicineDistantElementsEvaluationExposure toExternal Beam Radiation TherapyFibrosisFluorescenceFluorescence MicroscopyGenerationsGenetic TranscriptionGenotypeGoalsHalf-LifeHealthHeterogeneityHistologicHistologyImageImmuneImmune systemImmunohistochemistryImmunologyInfiltrationInhalationIntakeLeftLifeLinkLiverLocationLungLymphocyteLymphoid CellMapsMessenger RNAMicroRNAsMicroscopyModelingMolecularMolecular and Cellular BiologyMorphologyMotivationMusMyeloid CellsNatureNormal tissue morphologyNuclearNuclear Reactor AccidentsOrganOrganismOutcomeParticle SizeParticulatePatternPeriodicityPhenotypePositioning AttributeProductionPropertyRadiationRadiation ProtectionRadiation induced damageRadiobiologyRadioisotopesRadiology SpecialtyRecoveryResearchResourcesRoentgen RaysRouteSamplingSelection CriteriaSignal TransductionSlideSolubilitySourceSpleenTechnologyTimeTissue SampleTissuesTomogramToxic effectUniversitiesVertebral columnVisible Radiationanimal tissuebiomarker discoverybiomarker evaluationcell injurychemokinecytokinedensitydosimetryefficacy evaluationgraspimprovedin vivoinsightinternal radiationintravenous injectionlight microscopymacrophagemicroscopic imagingmorphometrynanoscaleradiation mitigationradiochemicalresponsesample archivesenescencestemsubmicronsynergismtissue archivetissue phantomtool
项目摘要
PROJECT 3: ABSTRACT
The overall objective of Project 3 is to link radionuclide exposure and the elemental signature left behind with
biomarkers of that exposure, be they histological, cellular or molecular in nature. Our motivation to do this stems
from the fact that radiation from internal emitters is very unevenly distributed in organs, tissues, and cells and
the fact that this remains little understood. Heterogeneity of radionuclide distribution is dependent upon a
complex set of parameters that relate to the radionuclide itself and the organism’s response to it, such as
radionuclide half-life, decay schema, activity, concentration, particle size, morphology, chemical form, and
solubility, whereas the biological response patterns are dictated by the genotype and phenotype of the cells,
tissues and organs, intake route and the organism as a whole.
Because the in vivo footprint of radionuclide exposure is multi-scale, e.g., DNA damage and cell death at the
(sub)cellular level, or chemokine/cytokine production at the cell/tissue level, it essentially means that biomarkers
of that exposure are best registered along the same multi-dimensional NANO-, MICRO- and MESO scale, which
is our goal. For example, micro-RNA expression will be registered in the context of immune cell infiltration in a
tissue, particularly macrophages. Arguably, the most compelling aspect to our project can be seen in the use of
X-ray fluorescent microscopy (XFM) as a powerful tool for radionuclide mapping, which forms the backbone to
our approach. Applying XFM technology to explore the incredibly rich resource that the Northwestern University
Radiation Animal (NURA) Archive, combined with contemporary animal models gives us the unique opportunity
to trace back the biological consequences of radionuclide exposures, and opens up the path towards biomarker,
and ultimately, to mitigator discovery. Canine and murine tissues from an enormous number of animals exposed
to a variety of radionuclides and over different times add critical mass and rigor to our study.
Collectively, our team can draw from a diverse set of expertise in nuclear medicine, cellular and molecular
biology, radiobiology, XFM, radiation protection and mitigation, normal tissue radiobiology and immunology. We
are ideally placed to carry out the proposed studies addressing the complexity of radionuclide exposure in a
comprehensive and integrated way. Our hope is to gain important insights into the biological consequences of
internal radiation emitters that are relevant to real life accidental and incidental exposure scenarios and that
cannot be modeled using conventional external beam radiation or nuclear medicine approaches. Yet, the
concepts underlying the interaction between radiation-damaged cells and tissues, danger signaling, the
engagement of immune system and the road to recovery are likely applicable in a much broader context.
项目3:摘要
项目3的总体目标是将放射性核素照射和留下的元素特征与
暴露的生物标志物,无论是组织学的、细胞的还是分子的。我们这样做的动机源于
来自内部发射器的辐射在器官、组织和细胞中分布非常不均匀,
这一事实仍然鲜为人知。放射性核素分布的异质性取决于
与放射性核素本身和生物体对它的反应有关的一组复杂参数,例如
放射性核素半衰期、衰变模式、活性、浓度、粒度、形态、化学形式,以及
溶解性,而生物反应模式由细胞的基因型和表型决定,
组织和器官,摄入途径和整个生物体。
因为放射性核素暴露的体内足迹是多尺度的,例如,DNA损伤和细胞死亡
(亚)细胞水平或细胞/组织水平的趋化因子/细胞因子产生,其基本上意味着生物标志物
最好的记录是沿着相同的多维纳米,微米和中尺度,
上网为目标例如,微RNA表达将在免疫细胞浸润的背景下在免疫细胞中被记录。
尤其是巨噬细胞。可以说,我们项目最引人注目的方面可以看出,
X射线荧光显微镜(XFM)作为放射性核素绘图的有力工具,
我们的方法。应用XFM技术来探索西北大学令人难以置信的丰富资源,
辐射动物(ARMA)档案,与当代动物模型相结合,为我们提供了独特的机会
追溯放射性核素暴露的生物后果,并开辟了生物标志物的道路,
并最终减轻发现的风险。大量动物的犬和鼠组织
各种放射性核素和在不同的时间增加临界质量和严谨性,我们的研究。
总的来说,我们的团队可以从核医学、细胞和分子医学的各种专业知识中汲取经验,
生物学、放射生物学、XFM、辐射防护和缓解、正常组织放射生物学和免疫学。我们
是开展拟议研究的理想场所,
全面和综合的方式。我们的希望是获得重要的见解,
与真实的生活中的意外和偶然暴露场景相关的内部辐射发射器,
不能使用常规的外部射束辐射或核医学方法来建模。然而
辐射损伤细胞和组织之间相互作用的基本概念,危险信号,
免疫系统的参与和恢复之路可能适用于更广泛的背景。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GAYLE E. WOLOSCHAK其他文献
GAYLE E. WOLOSCHAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GAYLE E. WOLOSCHAK', 18)}}的其他基金
Dosimetry and health effects of internal radionuclides
内部放射性核素的剂量测定和健康影响
- 批准号:
10753881 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination
内部放射性核素污染后毒性的多尺度评估和减轻
- 批准号:
10327393 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:
Project 3: Elemental Microscopy for Detection of Radionuclide Distribution and Development of Cell and Tissue Phantoms
项目 3:用于检测放射性核素分布和细胞和组织模型开发的元素显微镜
- 批准号:
10589884 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:
Multi-Scale Evaluation and Mitigation of Toxicities Following Internal Radionuclide Contamination
内部放射性核素污染后毒性的多尺度评估和减轻
- 批准号:
10589865 - 财政年份:2022
- 资助金额:
$ 37.45万 - 项目类别:
Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison
辐射诱发的癌症风险降低作为剂量延长的函数:种间比较
- 批准号:
10216194 - 财政年份:2017
- 资助金额:
$ 37.45万 - 项目类别:
Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison
辐射诱发的癌症风险降低作为剂量延长的函数:种间比较
- 批准号:
9401815 - 财政年份:2017
- 资助金额:
$ 37.45万 - 项目类别:
Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison
辐射诱发的癌症风险降低作为剂量延长的函数:种间比较
- 批准号:
9980304 - 财政年份:2017
- 资助金额:
$ 37.45万 - 项目类别:
Radiation induced cancer risk reduction as a function of dose protraction: interspecies comparison
辐射诱发的癌症风险降低作为剂量延长的函数:种间比较
- 批准号:
9752500 - 财政年份:2017
- 资助金额:
$ 37.45万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Standard Grant